A long term complex study also requiring compounding within 24 hours of drug administration for 57 patients in three sites across the UK, two weekly infusions for an average of three years in follow up treatment phase, alternating between home and inpatient administration.

The MRN trained in the region of 40 nurses to ensure continuity of care and achieved a patient retention rate of 98%; only one patient was lost from this study. A post trial patient assessment was also carried out yielding the following positive outcomes:

Overall satisfaction: 9.5 (out of ten)
Quality of care: 9.5 (out of ten)
Feeling of safety: 9.4 (out of ten)
Cost (to you): 9.6 (out of ten)
Convenience: 9.4 (out of ten)

Importance of homecare in trial participation:
Very important – 8
Quite important – 4
Somewhat important – 3
Not important – 5

Importantce of homecare in trial continuation:
Very important – 10
Quite important – 4
Somewhat important – 2
Not important – 4